Figure 1From: First-cycle absolute neutrophil count can be used to improve chemotherapy-dose delivery and reduce the risk of febrile neutropenia in patients receiving adjuvant therapy: a validation studyComparison of receiver-operating-characteristic curves for multiple logistic regression models derived from the study by Silber and colleagues [1] (n = 95), the MDACC study (n = 143), and the cross-validation of the Silber model with the MDACC data. Dotted line, Silber model; broken line, MDACC data; solid line, cross-validation.Back to article page